Design and in vitro characterization of Eudragit containing mucoadhesive buccal patches

International Journal of PharmTech Research

Volumn 1, Issue 3, 2009, Pages 783-789

  Patel, Vishnu M ^a   Prajapati, Bhupendra G ^b   Patel, Madhabhai M ^c  

^a APMC College of Pharmaceutical Education and Research   (India)

^b GANPAT UNIVERSITY   (India)

^c Kalol Institute of Pharmacy   (India)

Author keywords

Buccal patches; Eudragit; Mucoadhesive

Indexed keywords

CARBOMER; EUDRAGIT; POLYMER; POVIDONE; PROPRANOLOL; SOLVENT;

ANIMAL TISSUE; ARTICLE; CHEEK MUCOSA; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG RELEASE; DRUG SOLUBILITY; EX VIVO STUDY; IN VITRO STUDY; MUCOADHESION; NONHUMAN; PH; SHEEP; THICKNESS;

EID: 77953432883     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Gavini E, Sanna V, Juliano C, Bonferoni MC, Giunchedi P. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, Acriflavine. AAPS PharmSciTech.2003; 3(3): E20.
2. Chowdary KPR, Rao YS. Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: a technical note. AAPS PharmSciTech.2003; 4(3): E39.
3. Pramodkumar TM, Desai KGM, Shivkumar HG. Buccal permeation enhancers. Ind J Pharm Edu. 2002; 36: 147-151.
4. Collins AE, Deasy PB. Bio-adhesive lonzenge for the improved delivery of cetylpyridinium chloride. J Pharm Sci. 1990; 79: 116-119.
5. Cid E, Mella F, Lucchini L, Carcamo M, Monasterio J. Plasma concentrations and bioavailability of propranolol by oral, rectal and intravenous administration in man. Biopharm Drug Dispos. 1986; 7: 559-566.
6. Shand DG, Nickolis EM, Oates JA. Plasma propranolol levels in adults with observation in four children. Clin Pharmacol Ther. 1970; 11:112-118.
7. Garnpimol CR, Thawatchai P, Tamotsu K. Moist heart treatment on physicochemical change of chitosan salt films. Int J Pharm. 2002; 232: 11-22.
8. Khurana R, Ahuja A, Khar RK. Development and evaluation of mucoadhesive films of miconazole nitrate. Indian J Pharm Sci. 2000; 62: 449-453.
9. rd Edn., Vol. II, Controller of Publications, Ministry of Health, Govt. of India, New Delhi. 1996; 634-634.
10. Kemken J, Ziegler A, Muller BW. Pharmacodynamic effects of transdermal bupranolol and timolol in vivo: comparison of micro emulsions and matrix patches as vehicle. Math Find Exp Clinical Pharmacol. 1991; 13:361-365.
11. Gupta A, Garg S, Khar RK. Measurement of bioadhesive strength of muco-adhesive buccal tablets: design of an in-vitro assembly. Indian drugs.1992; 30: 152-155.
12. Bottenberg P, Cleymaet R, Muynek CD, Remon JP, Coomans D, Slop D. Development and testing of bioadhesive, floride-containg slow-release tablets for oral use. J Pharm Pharmacol. 1991; 43: 457-464.
13. Okamoto H, Taguchi H, Iido K, Danjo K. Development of polymer film dosage forms of lidocaine for buccal administration.I Penetration rate and release rate. J Control Release. 2001; 77: 253-260.
14. Perioli L, Ambrogi V, Angelici F, Ricci M, Giovagnoli S, Capuccella M, Rossi C. Development of mucoadhesive patches for buccal administration of ibuprofen. J Control Release. 2004; 99: 73-82.
15. Ilango R, Kavimani S, Mullaicharam AR, Jayakar B. In-vitro studies on buccal strips of glibenclamide using chitosan. Indian J Pharm Sci. 1997; 59 (5): 232-235.
16. Peppas NA, Bury PA. Surface interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Control Release. 1985; 2: 257-275.
17. Park H, Robinson JR. Mechanisms of bioadhesion of poly (acrylic acid) hydrogels. Pharm Research. 1987; 4: 457-464.
18. Parodi B, Russo E, Caviglioli G, Cafaggi S, Bignardi G. Development and characterization of a buccoadhesive dosage form of oxycodone hydrochloride. Drug Dev Ind Pharm. 1996; 22:445-450.
19. Walle T, Conradi EC, Walle UK, Fagan TC, Gaffney TE. The predictable relationship between plasma levels and dose during chronic propranolol therapy. Clin Pharmacol Ther. 1978; 24: 668-677.